Document Detail


Natriuretic peptides and long-term mortality in patients with severe aortic stenosis.
MedLine Citation:
PMID:  22808834     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND AND AIM OF THE STUDY: The natriuretic peptides, brain natriuretic peptide (BNP) and its N-terminal prohormone (NT-proBNP), can be used as diagnostic and prognostic markers for aortic stenosis (AS). However, the association between BNP, NT-proBNP, and long-term clinical outcomes in patients with severe AS remains uncertain.
METHODS: A total of 64 patients with severe AS was prospectively enrolled into the study, and underwent clinical and echocardiographic assessments at baseline. Blood samples were drawn for plasma BNP and NT-proBNP analyses. The primary outcome was death from any cause, through a six-year follow up period. Cox proportional hazards modeling was used to examine the association between natriuretic peptides and long-term mortality, adjusting for important clinical factors.
RESULTS: During a mean period of 1,520 +/- 681 days, 51 patients (80%) were submitted to aortic valve replacement, and 13 patients (20%) were medically managed without surgical interventions. Mortality rates were 13.7% in the surgical group and 62% in the medically managed group (p < 0.001). Patients with higher plasma BNP (> 135 pg/ml) and NT-proBNP (> 1,150 pg/ml) levels at baseline had a greater risk of long-term mortality (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.1-9.1; HR 4.3, 95% CI 1.4-13.5, respectively). After adjusting for important covariates, both BNP and NT-proBNP remained independently associated with long-term mortality (HR 2.9, 95% CI 1.5-5.7; HR 1.8, 95% CI 1.1-3.1, respectively).
CONCLUSION: In patients with severe AS, plasma BNP and NT-proBNP levels were associated with long-term mortality. The use of these biomarkers to guide treatment might represent an interesting approach that deserves further evaluation.
Authors:
Marcelo Katz; Flavio Tarasoutchi; Antonio Eduardo Pereira Pesaro; Renato D Lopes; Guilherme Sobreira Spina; Marcelo Luiz Campos Vieira; Max Grinberg
Related Documents :
22294344 - Sustained response and prevention of damage progression in patients with neonatal-onset...
22344184 - Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis i...
18086064 - Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of rand...
12732464 - Prevalence of benzimidazole resistant nematodes in sheep flocks in yucatan, mexico.
18397874 - Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 ...
8781634 - Prolonged treatment with omeprazole does not improve the eradication rate of helicobact...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of heart valve disease     Volume:  21     ISSN:  0966-8519     ISO Abbreviation:  J. Heart Valve Dis.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-07-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312096     Medline TA:  J Heart Valve Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  331-6     Citation Subset:  IM    
Affiliation:
Heart Institute, University of Sao Paulo Medical School, Brazil. mksp1975@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Slow rate of progression of grade 1 and 2+ aortic regurgitation.
Next Document:  The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic scle...